29/03/2022
Victor Sokolov made a presentation entitled “A multi-disease QSP platform in diabetes: the model-based study of SGLT2 inhibitors”. This study establishes a connection between the dapagliflozin-mediated
M&S Decisions participated in the World Conference on Pharmacometrics (WCoP 2022), hybrid meeting.
